DGAP-News

STRATEC converts to registered shares

DGAP-News: STRATEC Biomedical AG / Key word(s): Miscellaneous
STRATEC converts to registered shares

25.08.2015 / 09:57

---------------------------------------------------------------------

STRATEC converts to registered shares

Birkenfeld, August 25, 2015

STRATEC Biomedical AG, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard,
TecDAX) is converting its share capital, currently comprising 11,846,595
shares, after the close of trading on Friday, August 28, 2015, at a ratio
of 1:1 from bearer shares with a nominal amount of EUR 1.00 to registered
shares in the form of no-par shares (shares without a nominal amount).
Shareholdings will be converted by custodian banks and at no charge to
shareholders.

This conversion to registered shares, which was approved by the Annual
General Meeting on May 22, 2015, is meant to facilitate direct
communication with shareholders and increase transparency of the
shareholder structure.

All shares in STRATEC Biomedical AG will be listed in the Regulated Market
of the Frankfurt Stock Exchange (Prime Standard) as registered shares for
the first time on Monday, August 31, 2015. From this point onwards, only
the new international and German security identification numbers will be
valid, namely ISIN DE000STRA555 (to date DE000728900) and WKN STRA55 (to
date 728900). The company's ticker symbol SBS will remain unchanged.

Further information about this conversion to registered shares can be found
at www.stratec.com/registered_shares.

About STRATEC
STRATEC Biomedical AG (www.stratec.com) designs and manufactures fully
automated analyzer systems for its partners in the fields of clinical
diagnostics and biotechnology. These partners market such systems, in
general together with their own reagents, as system solutions to
laboratories, blood banks and research institutes around the world. The
company develops its products on the basis of its own patented
technologies.
Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard
segment of the Frankfurt Stock Exchange and are listed in the TecDAX select
index of the German Stock Exchange.

Further information can be obtained from:
STRATEC Biomedical AG
André Loy, Corporate Communications
Gewerbestr. 37, 75217 Birkenfeld
Germany
Tel: [phone]
Fax: [phone]
[e-mail]
www.stratec.com



---------------------------------------------------------------------

25.08.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Internet: www.stratec.com
ISIN: DE0007289001
WKN: 728900
Indices: TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
388993 25.08.2015